MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

Summary

Europe is considering unified drug pricing mechanisms to counter US pressure for higher pharmaceutical spending, with larger European nations showing resistance while smaller countries remain uncertain about the approach.